(-)-Epigallocatechin gallate (EGCG) has been associated with multiple beneficial effects. However, EGCG is known to be degraded by the gut microbiota. The present study investigated the hypothesis that microbial metabolism would create major catechol-moiety-containing microbial metabolites with different ability from EGCG to induce nuclear factor-erythroid 2-related factor 2 (Nrf2)-mediated gene expression. A reporter gene bioassay, label-free quantitative proteomics and reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) were combined to investigate the regulation of Nrf2-related gene expression after exposure of U2OS reporter gene or Hepa1c1c7 cells in vitro to EGCG or to its major microbial catechol-moiety-containing metabolites: (-)-epigallocatechin (EGC), gallic acid (GA) and pyrogallol (PG). Results show that PG was a more potent inducer of Nrf2-mediated gene expression than EGCG, with a 5% benchmark dose (BMD5) of 0.35 µM as compared to 2.45 µM for EGCG in the reporter gene assay. EGC and GA were unable to induce Nrf2-mediated gene expression up to the highest concentration tested (75 µM). Bioinformatical analysis of the proteomics data indicated that Nrf2 induction by PG relates to glutathione metabolism, drug and/or xenobiotics metabolism and the pentose phosphate pathway. Taken together, our findings demonstrate that the microbial metabolite PG is a more potent inducer of Nrf2-associated gene expression than its parent compound EGCG.
(−)-Epigallocatechin
gallate (EGCG) is prone to microbial
metabolism when reaching the colon. This study aimed to develop a
human physiologically based kinetic (PBK) model for EGCG, with sub-models
for its colonic metabolites gallic acid and pyrogallol. Results show
that the developed PBK model could adequately predict in vivo time-dependent blood concentrations of EGCG after either the single
or repeated oral administration of EGCG under both fasting and non-fasting
conditions. The predicted in vivo blood C
max of EGCG indicates that the Nrf2 activation is limited,
while concentrations of its metabolites in the intestinal tract may
reach levels that are higher than that of EGCG and also high enough
to activate Nrf2 gene transcription. Taken together, combining in vitro data with a human PBK model allowed the prediction
of a dose–response curve for EGCG-induced Nrf2-mediated gene
expression in humans and provided insights into the contribution of
gut microbial metabolites to this effect.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.